You have 9 free searches left this month | for more free features.

Norgestimate

Showing 26 - 50 of 192

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rhegmatogenous Retinal Detachment Trial in Boston (Pars plana vitrectomy, Triamcinolone Acetonide 40mg/mL, Moxifloxacin 0.5% or

Recruiting
  • Rhegmatogenous Retinal Detachment
  • Pars plana vitrectomy
  • +4 more
  • Boston, Massachusetts
    Massachusetts Eye and Ear
Jul 26, 2022

Healthy Volunteers Trial in Miami, Marlton, Austin (Oral Contraceptive (Ortho Tri-Cyclen or its generic equivalent), CC-99677)

Completed
  • Healthy Volunteers
  • Oral Contraceptive (Ortho Tri-Cyclen or its generic equivalent)
  • CC-99677
  • Miami, Florida
  • +2 more
Oct 21, 2021

Endocarditis Infective Trial in Barcelona (Cefaclor, Ciprofloxacin Tablets, Ciprofloxacin Injection)

Not yet recruiting
  • Endocarditis Infective
  • Barcelona, Spain
    Hospital Clinic i Provincial de Barcelona
May 26, 2022

Phenylketonuria Trial in Fargo (sapropterin diHCl, Moxifloxacin, Moxifloxacin )

Completed
  • Phenylketonuria
  • sapropterin dihydrochloride
  • +2 more
  • Fargo, North Dakota
    PRACS Institute, Ltd.
Jul 19, 2021

Breast Cancer Trial in Guangzhou (standard adjuvant chemo plus moxifloxacin, standard adjuvant chemo plus )

Recruiting
  • Breast Cancer
  • standard adjuvant chemotherapy plus moxifloxacin
  • standard adjuvant chemotherapy plus placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 14, 2021

COPD Exacerbation Acute Trial in China (Sitafloxacin, Moxifloxacin Hydrochloride)

Recruiting
  • COPD Exacerbation Acute
  • Changsha, China
  • +12 more
Sep 6, 2022

Asthma, COPD (COPD) Trial in Baltimore (CHF5993, CHF5259, Moxifloxacin 400mg)

Recruiting
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Baltimore, Maryland
    PAREXEL Baltimore Early Phase Clinical Unit
Apr 13, 2023

Healthy Subject Trial in Beijing (Orelabrutinib and (orelabrutinib tablet simulator), Orelabrutinib, Placebo (orelabrutinib

Active, not recruiting
  • Healthy Subject
  • Orelabrutinib and placebo (orelabrutinib tablet simulator)
  • +3 more
  • Beijing, China
    Beijing GoBroad Boren Hospital
Dec 19, 2022

Healthy Trial in Tempe (Danicopan, Moxifloxacin-matching Placebo, Danicopan-matching )

Completed
  • Healthy
  • Tempe, Arizona
    Clinical Trial Site
Aug 16, 2021

Headache, Migraine Trial in United States (Erenumab, Ethynil Estradiol/Norgestimate Oral Contraceptive)

Completed
  • Headache, Migraine
  • Erenumab
  • Ethynil Estradiol/Norgestimate Oral Contraceptive
  • Anaheim, California
  • +3 more
Jun 6, 2018

Healthy Volunteer Trial in Miami (ANG-3777 (Therapeutic Dose), ANG-3777 (Supra-therapeutic Dose), Placebo)

Not yet recruiting
  • Healthy Volunteer
  • ANG-3777 (Therapeutic Dose)
  • +3 more
  • Miami, Florida
    Quotient Sciences
May 27, 2021

Combined Oral Contraceptives and Body Weight in Pre-Menopausal

Recruiting
  • Contraceptive Usage
  • +4 more
    • Aurora, Colorado
    • +1 more
    Jul 20, 2022

    Drug-induced QT Prolongation, Pharmacokinetics, Pharmacodynamics Trial in West Bend (Clarithromycin, Pimozide, Placebo (Part 1))

    Not yet recruiting
    • Drug-induced QT Prolongation
    • +2 more
    • West Bend, Wisconsin
      Spaulding Clinical Research
    Feb 7, 2023

    Symptomatic Neurogenic Orthostatic Hypertension, nOH Trial in Tempe (Ampreloxetine <Dose A>, Ampreloxetine <Dose B>,

    Completed
    • Symptomatic Neurogenic Orthostatic Hypertension
    • nOH
    • Ampreloxetine <Dose A>
    • +4 more
    • Tempe, Arizona
      Theravance Biopharma Investigational Site
    Apr 19, 2021

    Restless Legs Syndrome Trial in Austin (GEn 1200mg, Gen 6000 mg, GEn Placebo)

    Completed
    • Restless Legs Syndrome
    • GEn 1200mg
    • +4 more
    • Austin, Texas
      GSK Investigational Site
    Apr 7, 2021

    Community-acquired Pneumonia, Sepsis, Inflammatory Response Trial in Greece (Tablets, Clarithromycin 500mg)

    Active, not recruiting
    • Community-acquired Pneumonia
    • +5 more
    • Alexandroupolis, Greece
    • +25 more
    Jan 11, 2023

    Pediculosis Trial in West Bend (Ha44, Ha44 Placebo, Moxifloxacin Placebo)

    Completed
    • Pediculosis
    • West Bend, Wisconsin
      Spaulding Clinical
    Jul 8, 2021

    Helicobacter Infection Trial in Seongnam-si (10 day sequential therapy (Esomeprazole, amoxicillin, clarithromycin,

    Recruiting
    • Helicobacter Infection
    • 10 day sequential therapy (Esomeprazole, amoxicillin, clarithromycin, metronidazole)
    • +3 more
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      Seoul National University Bundang Hospital
    Mar 22, 2021

    Duchenne and Becker Muscular Dystrophy, Polycytemia Vera Trial in Québec (ITF2357 10 mg/mL, Placebo, Moxifloxacin Hydrochloride)

    Completed
    • Duchenne and Becker Muscular Dystrophy
    • Polycytemia Vera
    • ITF2357 10 mg/mL
    • +2 more
    • Québec, Canada
      Québec
    Aug 25, 2021

    Female Sexual Dysfunction, Polycystic Ovary Syndrome Trial in Dayton, Hershey (Vitamin D, Hormonal contraception)

    Completed
    • Female Sexual Dysfunction
    • Polycystic Ovary Syndrome
    • Vitamin D
    • Hormonal contraception
    • Dayton, Ohio
    • +1 more
    Mar 23, 2022

    Infection, Human Immunodeficiency Virus Trial (BMS-955176, Ortho Cyclen)

    Completed
    • Infection, Human Immunodeficiency Virus
    • (no location specified)
    Apr 13, 2018

    Birth Control Compliance Trial in Chicago (Ortho Tri-cyclen Lo, NuvaRing)

    Completed
    • Birth Control Compliance
    • Ortho Tri-cyclen Lo
    • NuvaRing
    • Chicago, Illinois
    • +2 more
    Jan 13, 2021

    Osteomyelitis Trial in Louisville (oral antibiotics, intravenous antibiotics)

    Terminated
    • Osteomyelitis
    • oral antibiotics
    • intravenous antibiotics
    • Louisville, Kentucky
      University of Louisville
    Apr 2, 2021

    Healthy Trial in Tempe (JNJ-64565111, Moxifloxacin, JNJ-64565111-matching Placebo)

    Completed
    • Healthy
    • Tempe, Arizona
      Celerion
    Mar 2, 2020

    Prolonged QTc Interval, Pharmacokinetic Trial in West Bend (100 µg cebranopadol, 200 µg cebranopadol, 400 µg cebranopadol)

    Completed
    • Prolonged QTc Interval
    • Pharmacokinetic
    • 100 μg cebranopadol
    • +5 more
    • West Bend, Wisconsin
      US001 Contract research organization
    Jul 13, 2021